Clinical Trials Logo

Clinical Trial Summary

Aim of the study: To assess the role of intralipid emulsion in the acute man-agement of organophosphorus toxicity and its benefits in de-creasing mortality rates among victims.


Clinical Trial Description

Organophosphates (OPs) are cholinesterase inhibitors that are widely used as pesticides and organophosphate (OP) poisoning is an important public health concern in Egypt especially in the rural farming population. Organophosphate toxicity lead to a characteristic toxidrome that includes muscarinic, nicotinic and central nervous system signs and symptoms and, without proper and early antidotal treatment, death. A new antidote is the need of the hour. Lipid emulsion being inexpensive, easily available and effective in management of other lipid soluble toxins may be a novel option. The exact mechanisms by which ILE exert their beneficial effects are not fully understood, and several have suggested synergistic effects of several mechanisms. The mechanisms of action can be divided into intravascular, membrane, and intracellular effects. The original theory explaining the mechanism of lipid rescue was that of "lipid sink", suggesting sequestration of lipophilic compounds to an expanded intravascular lipid phase, extracting the offending agent from the target tissue, and reversing the toxicity. Other hypotheses relate to the mechanism by which ILEs facilitate cardiac rescue from drug poisoning. These include: 1. increasing myocardial energy substrate delivery and a direct cardiotonic effect of ILE on the poisoned heart. 2. an effect of ILE on calcium ion channels through high levels of long-chain fatty acids, leading to increased cardiomyocyte calcium and positive inotropic effect. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04393103
Study type Interventional
Source Assiut University
Contact Ahmad Hashem Sleem
Phone +201002954939
Email ahmad_hs_87@med.aun.edu.eg
Status Not yet recruiting
Phase Phase 2/Phase 3
Start date April 2024
Completion date January 2026

See also
  Status Clinical Trial Phase
Recruiting NCT06111352 - Outcome of Moderate Severity in OPC Poisoning Patients When Treated With Pralidoxime Phase 2
Recruiting NCT06256796 - Fresh Frozen Plasma Transfusion in Acute Organophosphate Poisoning N/A
Completed NCT00947596 - A Study of Inhaled Atropine Sulfate in Healthy Adults Phase 1